A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
In tests with mice, inhalable exosomes created by Columbia biomedical engineers successfully delivered cancer treatment to the lungs and suppressed tumor growth without toxic side effects.
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient’s risk of heart disease.
A new study in mice reveals how the brain can identify familiar individuals and recall past experiences with them; the findings could shed light on disorders affecting memory.
The number of nurses holding state legislative office in the United States has declined significantly over the past decade, investigators from Columbia Nursing report in a new study.
Some cancer cells escape their tumors and stay dormant in other parts of the body before seeding metastases. Columbia researchers have identified a switch that could put the cells back to sleep.
Charels Drew, MD, earned his doctor of medical science degree at VP&S for research that led to the first large-scale blood bank program in the United States.
A combination of a diabetes drug and a PI3K inhibitor may have potential in preventing melanoma from spreading to the liver, according to a study from Columbia cancer researchers.